Importantly, cell cycle genes play an essential role in cancer development and certain gene products, such as polo-like kinas 1(PLK1) and Aurora Kinases, are over-expressed in human cancers and are therefore attractive drug targets for cancer therapy. This evidence concerns the gene PLK1 and cancer.